USINNOVE OPENS NEW HEALTHTECH AND MEDTECH HUB IN NEUCHÂTEL

Microcity has pre-opened Usinnove, a new HealthTech and MedTech hub in Neuchâtel-Serrières designed to support startups, SMEs and research spin-offs from idea to market. 

«Usinnove was created to accelerate health innovation by providing startups, SMEs and large companies with an agile environment to develop, test and validate their technologies before scaling them up.»

Stéphane Poggi

CEO, Microcity / Usinnove

On 28 April 2026, Microcity marked a new milestone for Neuchâtel’s innovation ecosystem with the soft opening of Usinnove, a hub dedicated to HealthTech, MedTech, life sciences and medical innovation. Located in Neuchâtel-Serrières, the site brings together laboratories, workspaces, technical expertise and access to a specialised network for companies developing technologies in medical diagnostics, biotechnology, digital health and advanced analytical systems. 

Usinnove was created to shorten the path between research, technology development and practical applications for patients and healthcare professionals. The site offers private and shared BSL-1 and BSL-2 laboratories, cell culture areas, microbiology and chemistry labs, a shared microlab, private offices, meeting rooms, collaborative spaces and a cafeteria designed to encourage exchange between residents and partners. This infrastructure gives startups, innovative SMEs, academic spin-offs and technology companies a place to develop, test and prepare their solutions for industrialisation within an integrated environment. 

Beyond physical infrastructure, Usinnove is part of Microcity’s Health & Life Sciences ecosystem, connecting companies with research institutes, universities of applied sciences, hospitals, investors and industrial partners. The initiative reflects Neuchâtel’s strong position at the intersection of microtechnology and life sciences, two fields that are increasingly shaping medical devices, diagnostics, connected health, automation and advanced measurement technologies. 

The first company to join Usinnove is Metromol, a Neuchâtel startup founded in 2021 by Damian Twerenbold and Samuel Wunderli. The company is developing cryodetection mass spectrometry technology with applications in medical diagnostics, biotechnology, pharmaceutical development and analytical sciences. Its arrival illustrates Usinnove’s role: providing a specialised environment where high-potential health and life sciences companies can grow, collaborate and move closer to market. 

Key Facts

  • 0

    Infrastruture & Equipment (BSL-1, BSL-2 laboratories and office space)

Explore More Success Stories